NewAmsterdam Pharma Company N.V. (NAMS) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q2'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Sales/Revenue | 3.04M | 32K | 348K | 19.14M | 2.98M | 12.77M | 29.11M | 2.28M | 1.4M | 803K | 1.72M | 5.5M | 5.5M | 48.98M | 51.72M | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | 2.08% | -99.75% | -98.8% | 740.06% | 112.56% | 1490.54% | - | 32.73% | - | -85.41% | -96.49% | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 500K | 59K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 16.45% | 184.38% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 2.54M | -27K | 348K | 19.14M | 2.98M | 12.77M | 29.11M | 2.28M | 1.4M | 803K | 1.72M | 5.5M | 5.5M | 48.98M | 51.72M | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 83.55% | -84.38% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | - | - | - | - | - |
| Gross Profit Growth % | -14.71% | -100.21% | -98.8% | 740.06% | 112.56% | 1490.54% | - | 32.73% | - | -85.41% | -96.49% | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 60.96M | 65.95M | 55.49M | 54.78M | 71.9M | 56M | 54.11M | 54.85M | 56.88M | 51.88M | 44.2M | 33.57M | 33.57M | 20.89M | 22.06M | 18.01M | 17.28M | 5.9M | 5.83M | 127.66K |
| OpEx % of Revenue | 2005.26% | 206103.13% | 15945.69% | 286.13% | 2414.47% | 438.47% | 185.89% | 2406.93% | 4060.17% | 6460.4% | 2574.2% | 609.88% | 609.88% | 42.65% | 42.65% | - | - | - | - | - |
| Selling, General & Admin | 23.45M | 27.36M | 24.52M | 27.26M | 27.15M | 24.31M | 17.28M | 15.3M | 14.45M | 8.71M | 9.86M | 5.2M | 5.2M | 4.87M | 5.14M | 1.85M | 653.81K | 830.76K | 821.22K | 127.66K |
| SG&A % of Revenue | 771.38% | 85496.88% | 7045.98% | 142.41% | 911.75% | 190.35% | 59.35% | 671.26% | 1031.62% | 1084.18% | 574.14% | 94.41% | 94.41% | 9.94% | 9.94% | - | - | - | - | - |
| Research & Development | 37.51M | 38.59M | 30.97M | 27.52M | 44.75M | 34.9M | 35.7M | 38.38M | 42.43M | 41.29M | 34.34M | 28.37M | 28.37M | 16.02M | 16.92M | 9.88M | 9.54M | 5.07M | 5.01M | 0 |
| R&D % of Revenue | 1233.88% | 120606.25% | 8899.71% | 143.72% | 1502.72% | 273.21% | 122.64% | 1684.03% | 3028.55% | 5142.22% | 2000.06% | 515.47% | 515.47% | 32.71% | 32.71% | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | -1000K | 1000K | 1000K | 0 | 1000K | 0 | 0 | 0 | 1 | 1 | 1000K | 1000K | 0 | 1 | 0 |
| Operating Income | -58.42M | -65.98M | -55.14M | -35.63M | -68.92M | -43.23M | -25M | -52.58M | -55.48M | -51.07M | -42.48M | -28.07M | -28.07M | 28.09M | 29.66M | -18.01M | -17.28M | -5.9M | -5.83M | -127.66K |
| Operating Margin % | -1921.71% | -206187.5% | -15845.69% | -186.13% | -2314.47% | -338.47% | -85.89% | -2306.93% | -3960.17% | -6360.4% | -2474.2% | -509.88% | -509.88% | 57.35% | 57.35% | - | - | - | - | - |
| Operating Income Growth % | 15.24% | -52.63% | -120.55% | 32.22% | -24.23% | 15.36% | - | -23.76% | - | -81.97% | -251.25% | -55.83% | -62.45% | 575.85% | 608.33% | -14009.42% | -1172.99% | -334.89% | -329.89% | - |
| EBITDA | -58.36M | -65.92M | -55.08M | -35.59M | -68.87M | -43.18M | -24.98M | -52.56M | -55.47M | -51.06M | -42.47M | -28.06M | -28.06M | 28.11M | 29.68M | -18.01M | -17.28M | -5.9M | -5.83M | 41.45K |
| EBITDA Margin % | -1919.67% | -206003.13% | -15827.3% | -185.9% | -2312.73% | -338.07% | -85.79% | -2306.1% | -3959.1% | -6358.78% | -2473.44% | -509.83% | -509.74% | 57.38% | 57.38% | - | - | - | - | - |
| EBITDA Growth % | 15.27% | -52.67% | -120.54% | 32.28% | -24.17% | 15.44% | - | -23.75% | - | -81.94% | -251.1% | -55.83% | -62.42% | 576.26% | 608.77% | -43548.37% | -1173.14% | -334.88% | -329.88% | - |
| D&A (Non-Cash Add-back) | 62K | 59K | 64K | 45K | 52K | 51K | 28K | 19K | 15K | 13K | 13K | 2.25K | 7.38K | 18.86K | 19.91K | 1.59K | 1.16K | 1.19K | 1.17K | 0 |
| EBIT | -58.42M | -65.98M | -72M | -35.63M | -68.92M | -111.74M | -23.87M | -51.4M | -55.48M | -51M | -42.48M | -28.07M | -28.07M | 28.09M | 29.66M | -12.35M | -11.51M | -5.9M | -5.83M | 41.45K |
| Net Interest Income | 4.04M | 6.47M | 6.71M | 7.05M | 7.35M | 4.49M | 4.44M | 4.87M | 3.08M | 789K | 1.13M | -49.99K | 707.21K | 102.85K | 13.12K | 2.92K | 1.78K | 7.02K | 4.45K | 851 |
| Interest Income | 4.04M | 6.47M | 6.71M | 7.05M | 7.35M | 4.49M | 4.44M | 4.87M | 3.08M | 2.52M | 4.23M | 0 | 707.21K | 102.85K | 13.12K | 2.92K | 1.78K | 7.02K | 4.45K | 851 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.73M | 3.1M | 49.99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 9.98M | -8.94M | -16.86M | 18.27M | 29.4M | -48.95M | 8.36M | 13.57M | -38.28M | 1.61M | 4.19M | -9.98M | -9.98M | 468.83K | 495.08K | -2.12M | 6.21M | 279.88K | 276.67K | 169.11K |
| Pretax Income | -48.44M | -74.92M | -72M | -17.36M | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -49.47M | -38.29M | -38.04M | -38.04M | 28.56M | 30.15M | -20.13M | -11.07M | -5.62M | -5.56M | 41.45K |
| Pretax Margin % | -1593.45% | -234134.38% | -20691.09% | -90.7% | -1327.3% | -721.71% | -57.19% | -1711.58% | -6692.86% | -6160.4% | -2230.11% | -691.13% | -691.13% | 58.3% | 58.3% | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | 0 | 27K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0.01% | 0% | 0% | -0.05% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -48.44M | -74.92M | -72M | -17.36M | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -49.49M | -38.29M | -38.04M | -38.04M | 28.56M | 30.15M | -20.13M | -11.07M | -5.62M | -5.56M | 41.45K |
| Net Margin % | -1593.45% | -234134.38% | -20691.09% | -90.7% | -1327.3% | -721.71% | -57.18% | -1711.58% | -6692.86% | -6163.76% | -2230.11% | -691.13% | -691.13% | 58.3% | 58.3% | - | - | - | - | - |
| Net Income Growth % | -22.55% | 18.72% | -332.54% | 55.48% | 57.85% | -86.23% | - | -1.87% | - | -30.1% | -234.09% | -88.99% | -243.65% | 607.87% | 642.54% | -48663.07% | -670.27% | -291.21% | -286.71% | - |
| Net Income (Continuing) | -48.44M | -74.92M | -72M | -17.36M | -39.53M | -92.18M | -16.65M | -39.01M | -93.77M | -49.49M | -38.29M | -38.04M | -38.04M | 28.56M | 30.15M | -20.13M | -11.07M | -5.62M | -5.56M | 41.45K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.40 | -0.65 | -0.61 | -0.15 | -0.34 | -0.98 | -0.18 | -0.41 | -1.06 | -0.52 | -0.43 | -2.20 | -23.22 | 0.67 | 0.68 | -1.73 | -0.82 | -0.43 | -0.43 | 0.00 |
| EPS Growth % | -17.65% | 33.67% | -238.89% | 63.41% | 67.92% | -88.46% | - | 4.65% | - | 76.36% | -164.18% | -27.17% | -2731.71% | 255.81% | 258.14% | - | -4810.18% | -2474.85% | -2474.85% | - |
| EPS (Basic) | -0.40 | -0.65 | -0.61 | -0.15 | -0.34 | -0.98 | -0.18 | -0.41 | -1.06 | -0.52 | -0.43 | -2.20 | -23.19 | 0.75 | 0.75 | -1.73 | -0.82 | -0.43 | -0.43 | 0.00 |
| Diluted Shares Outstanding | 121.1M | 114.4M | 119M | 112.51M | 116.12M | 97.03M | 94.75M | 94.71M | 82.16M | 82.48M | 81.85M | 18.36M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M |
| Basic Shares Outstanding | 121.1M | 114.4M | 119M | 112.51M | 116.12M | 97.03M | 94.75M | 94.71M | 82.16M | 82.48M | 81.85M | 18.36M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M | 17.75M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |